HealthQuad invests in LifeSigns to expand AI-led remote patient monitoring platform

HealthQuad, the growth venture arm of Quadria Group focused on backing healthcare models, has announced its latest investment in LifeSigns, an AI-powered remote patient monitoring platform.

The company stated that the investment reflects HealthQuad’s healthcare innovation-led investment thesis focused on moving healthcare from episodic and reactive care to continuous and predictive intelligence. According to the company, health systems globally are facing rising demand beyond metros, workforce constraints, and cost pressures, making continuous patient monitoring and early intervention increasingly important.

LifeSigns stated that it is using AI to build a layer of care that detects early signs of deterioration, enables clinical decisions, and supports patient care. The company added that with deployment across tier 2 cities, an occupancy-based pricing model and scalable infrastructure, it is working to expand access to healthcare services.

HealthQuad stated that the investment represents a focus on healthcare innovation where AI is used to deliver clinical impact at scale. As LifeSigns’ first institutional investor, HealthQuad said it will support the company through Quadria’s healthcare ecosystem, with a focus on international expansion across Southeast Asia and GCC markets, along with strengthening its AI-led technology stack through selective integrations.

HealthQuad Fund III, a successor to HealthQuad Fund I and Fund II, aims to invest in companies building scalable healthcare solutions.

Rahul Agarwal said, “Healthcare today is built on periodic observation while risk is real time. The future lies in continuous monitoring led predictive intelligence. LifeSigns is building that layer to detect deterioration early and enable timely intervention which can significantly improve outcomes and reduce healthcare costs at scale. This is a globally relevant model and where the next wave of healthcare will be built. With access to Quadria’s ecosystem, we are well positioned to help Hari and LifeSigns team to scale across global markets.”

Hari Subramaniam added, “No patient should deteriorate silently because systems are not designed to continuously monitor them. That belief built LifeSigns. Our platform has demonstrated both clinical impact and scalability in India. With HealthQuad and Quadria, we now have the strategic depth to take this model global and make predictive care the standard.”

The global remote patient monitoring devices market stands at USD 26 billion in 2025 as healthcare systems shift towards continuous and decentralised monitoring.

LifeSigns has developed a US-FDA approved monitoring platform integrating a wearable device, cloud dashboard, and predictive AI engine. The platform operates across ambulances, emergency rooms, ICUs, wards, and home care settings.

The platform tracks ECG, heart rate, respiration, temperature, blood pressure, and oxygen saturation. According to the company, its AI engine can detect early signs of deterioration up to 26 hours in advance and identify critical risk within a four-hour window. Across more than 50 hospitals in India, LifeSigns stated that it has delivered over 87,000 alerts, reduced code blue incidents by nearly 90 per cent, and lowered ICU readmissions by close to 78 per cent. The company added that its central monitoring command centre supports remote surveillance and operational management.